A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Clinical trial NCT04464759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04464759
- Sponsor
- Ravi Amaravadi, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2026-07-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.